|
C14ORF102 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52900003769219E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52349999282819E-09 |
| Normal-vs-Stage2 |
8.579600E-03 |
| Normal-vs-Stage3 |
5.53239999999677E-05 |
| Normal-vs-Stage4 |
7.356900E-03 |
| Stage1-vs-Stage2 |
8.747800E-01 |
| Stage1-vs-Stage3 |
9.323800E-01 |
| Stage1-vs-Stage4 |
2.802400E-01 |
| Stage2-vs-Stage3 |
8.442800E-01 |
| Stage2-vs-Stage4 |
2.956800E-01 |
| Stage3-vs-Stage4 |
2.351600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.0404001538642E-10 |
| Normal-vs-AfricanAmerican |
1.023320E-04 |
| Normal-vs-Asian |
5.257600E-02 |
| Caucasian-vs-AfricanAmerican |
1.239180E-01 |
| Caucasian-vs-Asian |
6.111400E-01 |
| AfricanAmerican-vs-Asian |
3.859000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69329994470502E-10 |
| Normal-vs-Female |
1.625110E-04 |
| Male-vs-Female |
4.514500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.89799999999308E-05 |
| Normal-vs-Extreme_Weight |
2.50300002946346E-10 |
| Normal-vs-Obese |
1.57498999999728E-05 |
| Normal-vs-Extreme_Obese |
6.00299999999887E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.605640E-01 |
| Normal_Weight-vs-Obese |
9.563800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.419600E-01 |
| Extreme_Weight-vs-Obese |
1.091810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.720400E-01 |
| Obese-vs-Extreme_Obese |
4.189400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.211900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.04229999997596E-06 |
| Normal-vs-Age(61-80Yrs) |
7.24910131921774E-11 |
| Normal-vs-Age(81-100Yrs) |
1.05689999996272E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.149000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.938200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.119800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.195600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.967790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.192800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.0752000118307E-09 |
| Normal-VS-Type2 PRCC |
9.12069975100849E-10 |
| Normal-VS-KIRP CIMP |
7.41749994759289E-09 |
| Normal-VS-Unclassified PRCC |
1.105670E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.031800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.480900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.236600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.142300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.240630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.972240E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.28480004413234E-10 |
| Normal-vs-N1 |
1.883250E-03 |
| Normal-vs-N2 |
6.71889999970254E-07 |
| N0-vs-N1 |
3.469400E-01 |
| N0-vs-N2 |
9.582200E-02 |
| N1-vs-N2 |
1.458770E-01 |
|
|
